Literature DB >> 24621977

The challenge of drug development in acute heart failure: balancing mechanisms, targeting patients, and gambling on outcomes.

Peter S Pang1, Michael M Givertz2.   

Abstract

Entities:  

Keywords:  acute heart failure; hemodynamics; neurohormone; randomized controlled trial; urocortin-2

Mesh：

Substances：

Year:  2013        PMID： 24621977     DOI： 10.1016/j.jchf.2013.08.004

Source DB:  PubMed          Journal:  JACC Heart Fail        ISSN： 2213-1779            Impact factor:   12.035


× No keyword cloud information.
  3 in total

1.  Biased ligand of the angiotensin II type 1 receptor in patients with acute heart failure: a randomized, double-blind, placebo-controlled, phase IIB, dose ranging trial (BLAST-AHF).

Authors:  Peter S Pang; Javed Butler; Sean P Collins; Gad Cotter; Beth A Davison; Justin A Ezekowitz; Gerasimos Filippatos; Phillip D Levy; Marco Metra; Piotr Ponikowski; John R Teerlink; Adriaan A Voors; David Bharucha; Kathleen Goin; David G Soergel; G Michael Felker
Journal:  Eur Heart J       Date:  2017-08-07       Impact factor: 29.983

2.  Vasodilators for acute heart failure-A protocol for a systematic review of randomized clinical trials with meta-analysis and Trial Sequential Analysis.

Authors:  Johannes Grand; Olav W Nielsen; Jacob Eifer Møller; Christian Hassager; Janus Christian Jakobsen
Journal:  Acta Anaesthesiol Scand       Date:  2022-08-23       Impact factor: 2.274

3.  Mode of presentation and mortality amongst patients hospitalized with heart failure? A report from the First Euro Heart Failure Survey.

Authors:  Ahmad Shoaib; M Farag; J Nolan; A Rigby; A Patwala; M Rashid; C S Kwok; R Perveen; A L Clark; M Komajda; J G F Cleland
Journal:  Clin Res Cardiol       Date:  2018-10-25       Impact factor: 5.460
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.